← Leaderboards
Megan Rist Haymart
University Of Michigan At Ann Arbor
$6,739,165
Attributed
$9,100,604
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,239,293 · 5
AHRQ$861,311 · 1
By mechanism
R01$4,574,707 · 3
RC2$3,097,384 · 1
K07$835,480 · 1
R34$593,033 · 1
Top collaborators
- Sarah T Hawley2 shared
- Predrag Klasnja1 shared
- Brahmajee K Nallamothu1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Masahito Jimbo$3,875,414
- Suzanne E Judd$21,734,940
- Sarah T Hawley$8,177,059
- Carolyn M Sampselle$11,022,903
- Ted Albert Skolarus$3,689,953
Others in their field
Top investigators on “Malignant Neoplasm Of Thyroid”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- James A Fagin · Sloan-Kettering Inst Can Research$18,343,965
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Stanley R Hamilton · Johns Hopkins University$17,360,724
- Larry Arthur$15,377,757
- Ignacio I. Wistuba · Ut Southwestern Medical Center$15,303,923
Research focus
Malignant Neoplasm Of ThyroidMalignant NeoplasmsIncidencePhysiciansFoundationsCancer PatientVariantSurveysRadioactive IodineThyroid HormonesPositioning AttributeLinkEndocrinologistAttitudeDiagnosisPhysician&AposDecision MakingPatternPopulation BasedS RoleDoseBenefits And RisksOperative Surgical ProceduresSurgeon
Grant awards (19)
mHealth Outcomes in Behavioral Interventions & Longitudinal Evaluation (MOBILE) Platform$3,097,384
RC2 · FY2025 · TR
Risk-stratified care for thyroid cancer survivors$656,421
R01 · FY2025 · CA · contact PI
Personalized Cancer Support for Young Adults$302,981
R34 · FY2025 · CA · contact PI
Risk-stratified care for thyroid cancer survivors$686,630
R01 · FY2024 · CA · contact PI
Personalized Cancer Support for Young Adults$290,052
R34 · FY2024 · CA · contact PI
Treatment decision making in low-risk thyroid cancer$367,473
R01 · FY2019 · CA · contact PI
Imaging Practices and Overdiagnosis of Thyroid Cancer$217,559
R01 · FY2019 · HS · contact PI
Treatment decision making in low-risk thyroid cancer$518,509
R01 · FY2018 · CA · contact PI
Imaging Practices and Overdiagnosis of Thyroid Cancer$214,460
R01 · FY2018 · HS · contact PI
Treatment decision making in low-risk thyroid cancer$200,000
R01 · FY2018 · CA · contact PI
Treatment decision making in low-risk thyroid cancer$759,437
R01 · FY2017 · CA · contact PI
Imaging Practices and Overdiagnosis of Thyroid Cancer$211,360
R01 · FY2017 · HS · contact PI
Treatment decision making in low-risk thyroid cancer$524,926
R01 · FY2016 · CA · contact PI
Imaging Practices and Overdiagnosis of Thyroid Cancer$217,932
R01 · FY2016 · HS · contact PI
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer$167,096
K07 · FY2015 · CA · contact PI
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer$167,096
K07 · FY2014 · CA · contact PI
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer$167,096
K07 · FY2013 · CA · contact PI
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer$167,096
K07 · FY2012 · CA · contact PI
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer$167,096
K07 · FY2011 · CA · contact PI